Pharmacist-based Donepezil Outpatient Consultation Service to improve medication persistence
Author(s) -
Keiko Yamamura,
Yusuke Suzuki,
Umegaki,
Katsuro Shigeno,
Ryo Matsushita,
Yoshimichi Sai,
Ken-ichi Miyamoto,
Kiyofumi Yamada
Publication year - 2012
Publication title -
patient preference and adherence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 48
ISSN - 1177-889X
DOI - 10.2147/ppa.s34984
Subject(s) - donepezil , medicine , pharmacist , persistence (discontinuity) , service (business) , family medicine , pharmacy , dementia , disease , geotechnical engineering , economy , engineering , economics
Donepezil is widely used to delay the progression of cognitive dysfunction in patients with Alzheimer's disease (AD), but the efficacy of pharmacotherapy is often reduced by poor adherence to medication. In order to improve adherence by providing information about AD and the significance of pharmacotherapy, the Donepezil Outpatient Consultation Service (DOCS) was set up. The influence of this service on medication persistence was assessed in the present study.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom